-
Nouvelles et mises à jour
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour -
Nouvelles plateformes en Colombie-Britannique et en Alberta pour faire progresser la santé cérébrale
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour/nouvelles-plateformes-en-colombie-britannique-et-en-alberta-pour-faire-progresser-la-santé-cérébraleDes chercheurs de la Colombie-Britannique et de l’Alberta lancent trois nouvelles plateformes de recherche sur le cerveau qui est à même de changer la façon dont les maladies neurologiques et mentales sont étudiées, diagnostiquées et traitées en rendant la recherche plus rapide, plus inclusive et...
-
Nouvelles subventions pour les Futurs leaders de Brain Canada
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour/bourses-pour-les-nouveaux-futurs-leadersLa Fondation Brain Canada (Brain Canada) est heureux d’annoncer la récente cohorte de bénéficiaires du programme Futurs leaders canadiens de la recherche sur le cerveau. Ce programme phare fournit un financement essentiel aux scientifiques en début de carrière dont les idées audacieuses font...
-
Novel approaches to central nervous system white matter repair
https://braincanada.ca/fr/subventions-financées/novel-approaches-to-central-nervous-system-white-matter-repairMany nerve cells in the body are covered with a protective sheath known as myelin, which allows fast conduction of nerve impulses, and which is produced by two different types of cells called oligodendrocytes and Schwann cells. Project Overview Many nerve cells in the body are covered with a...
-
Novel approaches to early detection and treatment of ASD
https://braincanada.ca/fr/subventions-financées/novel-approaches-to-early-detection-and-treatment-of-asdMore than 1 in 100 individuals are diagnosed with Autism Spectrum Disorder (ASD), with profound impacts on the quality of life of those who are affected and their families. Project Overview More than 1 in 100 individuals are diagnosed with Autism Spectrum Disorder (ASD), with profound impacts on...
-
Novel approaches to understand the role of cAMP and co-signaling cascades in synaptic plasticity and brain disorders
https://braincanada.ca/fr/subventions-financées/novel-approaches-to-understand-the-role-of-camp-and-co-signaling-cascades-in-synaptic-plasticity-and-brain-disordersSynaptic plasticity is the process where the strength of connections between nerve cells is altered by experience. Project Overview Synaptic plasticity is the process where the strength of connections between nerve cells is altered by experience. It is widely believed that synaptic plasticity is...
-
Novel biological agents in the treatment of amyotrophic lateral sclerosis based on progranulin/granulin structure
https://braincanada.ca/fr/subventions-financées/novel-biological-agents-in-the-treatment-of-amyotrophic-lateral-sclerosis-based-on-progranulin-granulin-structureChallenge: ALS (amyotrophic lateral sclerosis) is an incurable and invariably fatal motor neuron (MN) disease. Project Overview Challenge: ALS (amyotrophic lateral sclerosis) is an incurable and invariably fatal motor neuron (MN) disease. Our challenge is to develop a biologic-therapy that slows,...
-
Novel biomarkers of SOD1 pathology in familial and sporadic ALS
https://braincanada.ca/fr/subventions-financées/novel-biomarkers-of-sod1-pathology-in-familial-and-sporadic-alsMutations in the SOD1 gene, leading to the misfolding and toxic aggregation of SOD1 protein, are the second leading cause of Familial Amyotrophic Lateral Sclerosis (FALS-SOD1) and emerging literature has detected misfolded SOD1 (mSOD1) in the cerebrospinal fluid (CSF) and post-mortem tissue of...
-
Novel blood and neuroimaging markers of Alzheimer’s disease and cerebral amyloid angiopathy
https://braincanada.ca/fr/subventions-financées/novel-blood-and-neuroimaging-markers-of-alzheimer-s-disease-and-cerebral-amyloid-angiopathyAs our brains age, they become vulnerable to diseases such as Alzheimer’s disease which can cause dementia. Project Overview As our brains age, they become vulnerable to diseases such as Alzheimer’s disease which can cause dementia. Dementia is defined as cognitive (i.e., thinking) problems that...
-
Novel Cellular and Molecular Mechanisms Regulating Synapse Dysfunction in Alzheimer’s Disease
https://braincanada.ca/fr/subventions-financées/novel-cellular-and-molecular-mechanisms-regulating-synapse-dysfunction-in-alzheimer-s-diseaseIn Alzheimer s disease (AD), critical synaptic connections between neurons disintegrate and cells die. Project Overview In Alzheimer s disease (AD), critical synaptic connections between neurons disintegrate and cells die. The brains of individuals with AD accumulate plaques of a protein fragment...